pillbase.ru

Lokelma

Active substance: sodium zirconium cyclosilicate

sodium zirconium cyclosilicate

Centralised EU authorisationActive

Marketing holder: AstraZeneca AB

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 4
  • LOKELMA
    POWDER, FOR SUSPENSION · SODIUM ZIRCONIUM CYCLOSILICATE 5 g/5g
    50090-6502
    A-S Medication Solutions
  • LOKELMA
    POWDER, FOR SUSPENSION · SODIUM ZIRCONIUM CYCLOSILICATE 10 g/10g
    50090-6501
    A-S Medication Solutions
  • LOKELMA
    POWDER, FOR SUSPENSION · SODIUM ZIRCONIUM CYCLOSILICATE 5 g/5g
    0310-1105
    AstraZeneca Pharmaceuticals LP
  • LOKELMA
    POWDER, FOR SUSPENSION · SODIUM ZIRCONIUM CYCLOSILICATE 10 g/10g
    0310-1110
    AstraZeneca Pharmaceuticals LP
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208f-c5d6-76ac-b7d4-22913c608bdb,01a12095-f672-73d9-87b9-11c1566e3111,01a12096-d89d-78cb-8d6c-6cbf37cc80ca,01a1209d-d914-766d-89e5-bd47ff3e0d74;count=4 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/004029
Registration status
Active
ATC code
V03AE10
Sources
  • product · EMA · EMEA/H/C/004029 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/004029 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/004029 · Verified 2026-10-09